These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
516 related items for PubMed ID: 16414332
1. Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms. Liu JH. Am J Med; 2005 Dec 19; 118 Suppl 12B():88-92. PubMed ID: 16414332 [Abstract] [Full Text] [Related]
2. Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence. Garefalakis M, Hickey M. Clin Interv Aging; 2008 Dec 19; 3(1):1-8. PubMed ID: 18488873 [Abstract] [Full Text] [Related]
4. DHEA, important source of sex steroids in men and even more in women. Labrie F. Prog Brain Res; 2010 Dec 19; 182():97-148. PubMed ID: 20541662 [Abstract] [Full Text] [Related]
5. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Kenemans P, Speroff L, International Tibolone Consensus Group. Maturitas; 2005 May 16; 51(1):21-8. PubMed ID: 15883105 [Abstract] [Full Text] [Related]
10. Testosterone therapy in women: a review. Bolour S, Braunstein G. Int J Impot Res; 2005 Jul 16; 17(5):399-408. PubMed ID: 15889125 [Abstract] [Full Text] [Related]
11. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Labrie F, Luu-The V, Labrie C, Simard J. Front Neuroendocrinol; 2001 Jul 16; 22(3):185-212. PubMed ID: 11456468 [Abstract] [Full Text] [Related]
12. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society. North American Menopause Society. Menopause; 2005 Jul 16; 12(5):496-511; quiz 649. PubMed ID: 16145303 [Abstract] [Full Text] [Related]
13. Effects of estrogen/androgen therapy on bone mineral density parameters. Notelovitz M. J Reprod Med; 2001 Mar 16; 46(3 Suppl):325-31. PubMed ID: 11304880 [Abstract] [Full Text] [Related]
14. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication. Gregersen N, Jensen PT, Giraldi AE. Dan Med Bull; 2006 Aug 16; 53(3):349-53. PubMed ID: 17092454 [Abstract] [Full Text] [Related]
15. [Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects]. Gregersen N, Hilmand CB, Jensen PT, Giraldi AG. Ugeskr Laeger; 2006 Feb 06; 168(6):559-63. PubMed ID: 16476214 [Abstract] [Full Text] [Related]
16. Tibolone: a unique version of hormone replacement therapy. Swegle JM, Kelly MW. Ann Pharmacother; 2004 May 06; 38(5):874-81. PubMed ID: 15026563 [Abstract] [Full Text] [Related]
17. Tibolone: the way to beat many a postmenopausal ailments. Lazovic G, Radivojevic U, Marinkovic J. Expert Opin Pharmacother; 2008 Apr 06; 9(6):1039-47. PubMed ID: 18377345 [Abstract] [Full Text] [Related]
18. Androgen replacement in menopause. Burd ID, Bachmann GA. Curr Womens Health Rep; 2001 Dec 06; 1(3):202-5. PubMed ID: 12112971 [Abstract] [Full Text] [Related]
19. Menopause and sexual desire: the role of testosterone. Nappi RE, Albani F, Santamaria V, Tonani S, Martini E, Terreno E, Brambilla E, Polatti F. Menopause Int; 2010 Dec 06; 16(4):162-8. PubMed ID: 21156854 [Abstract] [Full Text] [Related]
20. Androgen and menopause. Somboonporn W. Curr Opin Obstet Gynecol; 2006 Aug 06; 18(4):427-32. PubMed ID: 16794424 [Abstract] [Full Text] [Related] Page: [Next] [New Search]